Evan Appleton, Ph.D.

Evan Appleton, Ph.D. is currently Head of Stem Cell Biology / Reprogramming at Colossal. Evan received his doctoral degree from Boston University in 2015 and completed a postdoc in the Church Lab at Harvard Medical School from 2016 until 2022 in stem cell biology and engineering of multicellular shapes from single cells. His expertise includes synthetic biology, computer aided design, and bioinformatics. Evan leads a team that derives induced pluripotent stem cells (iPSCs) from primary Asian Elephant cells and other non-model organisms and differentiates them into other cell types relevant for species conservation and de-extinction.